Virax Biolabs Group Limited (VRAX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 4.15M | 4.89M | 8.03M | 4.38M | 5.97M | 9.63M | 5.3M | 48.71K | 43.03K | 39.62K | 5.65K |
| Cash & Short-Term Investments | 3.35M | 4.23M | 7.38M | 3.59M | 5.11M | 9.35M | 4.57M | 21.76K | 11.68K | 17.62K | 5.65K |
| Cash Only | 3.35M | 4.23M | 7.29M | 3.59M | 5.11M | 9.35M | 4.57M | 21.76K | 11.68K | 17.62K | 5.65K |
| Short-Term Investments | 0 | 0 | 95.55K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 175.7K | 30.65K | 26.16K | 217.84K | 183.36K | 0 | 0 | 0 | 0 | 928 | 0 |
| Days Sales Outstanding | 5.85K | 1.88K | 2.25K | 229.04 | 218.71 | - | - | - | - | 3.08 | - |
| Inventory | 54.19K | 94.67K | 261.3K | 60.38K | 24.51K | 24.09K | 0 | 20.95K | 21.07K | 21.07K | 0 |
| Days Inventory Outstanding | 31.3 | 338.57 | 1.28K | 97.2 | 33.61 | 513.23 | - | 19.18 | - | 57.72 | - |
| Other Current Assets | 0 | 0 | 23.79K | 0 | 0 | 0 | 4.69K | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 1.57M | 1.53M | 1.41M | 1.1M | 1.05M | 178.4K | 0 | 0 | 54.5K | 54.5K | 0 |
| Property, Plant & Equipment | 1.57M | 1.53M | 1.36M | 1.1M | 679.42K | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | 0.00x | 0.00x | 0.00x | 0.09x | 0.11x | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 39.65K | 46.19K | 49.77K | 374.67K | 178.4K | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54.5K | 54.5K | 0 |
| Other Non-Current Assets | 0 | -39.65K | 0 | -49.77K | -1.05M | -178.4K | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 5.72M | 6.43M | 9.44M | 5.48M | 7.03M | 9.81M | 5.3M | 48.71K | 97.53K | 94.12K | 5.65K |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.00x | 0.00x | -1.27x | - | 2.20x | 4.42x |
| Asset Growth % | -39.48% | 17.19% | 34.41% | -44.11% | 32.58% | 20046.22% | 5333.16% | -48.25% | - | 1565.14% | - |
| Total Current Liabilities | 365.47K | 673.21K | 693.97K | 168.85K | 787.02K | 908.4K | 1.14M | 1.25M | 1.05M | 871.43K | 309.43K |
| Accounts Payable | 42.37K | 56.09K | 118.94K | 45.63K | 408.62K | 159.91K | 427.46K | 846.47K | 236.62K | 217.15K | 217.15K |
| Days Payables Outstanding | 20.7 | 166.48 | 657.11 | 520.12 | 393.12 | 6.26K | 10.3K | 494.46 | - | 594.79 | 5.86K |
| Short-Term Debt | 195.58K | 32.47K | 222.73K | 0 | 0 | 146.25K | 0 | 0 | 100K | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 38.25K | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 50.24K | 60.48K | 114.91K | 63.12K | 216.06K | 140.29K | 3.76K | 3.76K | 449.61K | 192K | 256.23K |
| Current Ratio | 11.35x | 7.27x | 11.58x | 25.94x | 7.59x | 10.61x | 4.64x | 0.04x | 0.04x | 0.05x | 0.02x |
| Quick Ratio | 11.21x | 7.13x | 11.20x | 25.58x | 7.56x | 10.58x | 4.64x | 0.02x | 0.02x | 0.02x | 0.02x |
| Cash Conversion Cycle | 5.87K | 2.05K | 2.87K | -193.87 | -140.8 | - | - | - | - | -533.99 | - |
| Total Non-Current Liabilities | 276.04K | 291.54K | 332.1K | 176.34K | 132.03K | 0 | 0 | 0 | 0 | 0 | 53.21K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 276.04K | 291.54K | 332.1K | 176.34K | 132.03K | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 53.21K |
| Total Liabilities | 641.52K | 964.75K | 1.03M | 345.19K | 919.05K | 908.4K | 1.14M | 1.25M | 1.05M | 871.43K | 309.43K |
| Total Debt | 537.99K | 377K | 603.2K | 224.3K | 181.71K | 146.25K | 3.76K | 3.76K | 179.48K | 179.48K | 0 |
| Net Debt | -2.81M | -3.85M | -6.68M | -3.36M | -4.93M | -9.21M | -4.57M | -18K | 167.8K | 161.86K | -5.65K |
| Debt / Equity | 0.11x | 0.07x | 0.07x | 0.04x | 0.03x | 0.02x | 0.00x | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -83.44x | -100.77x | -112.50x | -227.16x | -267.57x | -682.27x | -150.31x | -906.91x | -39.66x | -25.95x | -7.15x |
| Total Equity | 5.07M | 5.46M | 8.42M | 5.14M | 6.11M | 8.9M | 4.16M | -1.2M | -948.11K | -777.32K | -303.78K |
| Equity Growth % | -39.72% | 6.29% | 37.84% | -42.29% | 46.92% | 844.04% | 538.37% | -53.95% | - | -155.88% | - |
| Book Value per Share | 26.63 | 31.34 | 67.80 | 57.42 | 85.99 | 143.18 | 89.09 | -26.30 | -20.84 | -17.09 | -0.67 |
| Total Shareholders' Equity | 5.31M | 5.7M | 8.64M | 5.37M | 6.33M | 9.13M | 4.39M | -974.58K | -744.37K | -596.18K | -303.78K |
| Common Stock | 6.54K | 4.34K | 4.34K | 2.57K | 1.81K | 1.56K | 1.17K | 999 | 301 | 265 | 26 |
| Retained Earnings | -26.93M | -24.59M | -21.28M | -18.53M | -14.8M | -11.79M | -7.78M | -6.34M | -5.18M | -4.63M | -994.29K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 32.23M | 30.28M | 29.93M | 23.89M | 21.13M | 20.92M | 12.17M | 5.36M | 4.44M | 4.03M | 0 |
| Minority Interest | -238.47K | -233.97K | -228.12K | -227.98K | -226.95K | -222.4K | -236.76K | -222.13K | -203.74K | -181.13K | 0 |